(Source: Bayer AG) Leverkusen, July 1, 2013 - Bayer has completed the acquisition of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany. The transaction was cleared by the relevant antitrust authorities. Christian Sarto (43), previously responsible for HealthCare mergers and acquisitions at Bayer AG, has been named as Steigerwald's new Managing Director. Steigerwald specializes in pharmacy-only herbal medicines. Its product portfolio includes Iberogast® for the treatment of functional gastrointestinal disorders and Laif® for the treatment of mild to moderate depression....
↧